Stefan Buck

Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib

V. Koneti Rao, Sharon Webster, Virgil A. S. H. Dalm et al. · Blood · 2017 · 286 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy

Cristina Saura, Johanna C. Bendell, Guy Jérusalem et al. · Clinical Cancer Research · 2014 · 134 citations · Full text

Medicine, Oncology, Pharmacology +17

The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting

Matthias M. Zimmer, Anuja Kibe, Ulfert Rand et al. · Nature Communications · 2021 · 101 citations · Full text

Life Sciences, Biology, Molecular Biology +13

Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery

Nathalie Gobeau, Rowan Stringer, Stefan Buck et al. · Pharmaceutical Research · 2016 · 64 citations

Pharmacy, Pharmacokinetics, Compartmental Analysis +9

Diruthenium(I,I) Catalysts for the Formation of β‐ and γ‐Lactams <i>via</i> Carbenoid CH Insertion of α‐Diazoacetamides

Markus Grohmann, Stefan Buck, L. Schaffler et al. · Advanced Synthesis & Catalysis · 2006 · 56 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9